Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

214.20p
   
  • Change Today:
      4.40p
  • 52 Week High: 215.40
  • 52 Week Low: 94.55
  • Currency: UK Pounds
  • Shares Issued: 725.31m
  • Volume: 1,434,889
  • Market Cap: £1,553.62m
  • RiskGrade: 314

Indivior lifts 2021 guidance after better-than-expected H1

By Michele Maatouk

Date: Wednesday 30 Jun 2021

LONDON (ShareCast) - (Sharecast News) - Opioid addiction treatment maker Indivior lifted its 2021 guidance on Wednesday following a better-than-expected business performance through the first half of the year.
The company now expects total full-year revenue of between $705m and $740m, up from previous guidance of up to $625m. This reflects a stronger performance from its Sublocade drug, a continued more modest rate of Soboxone film market share erosion for the remainder of the year and FX benefits of around $10m.

For Sublocade, its now expects FY revenue of between $210m and $230m, up from guidance of between $185m and $210m. This is based stronger demand and a large order from a new criminal justice system customer.

The company's revenue guidance for Perseris was unchanged at between $17m and $20m.

Indivior also said its adjusted gross margin is set to be in the low-80%s range, modestly above previous expectations due to relative stability in the commercial channel for Suboxone film.

Meanwhile, adjusted operating expenses will be in the range of $470m to $480m, compared to $420m to $440m expected previously.

Indivior did not provide any numbers but said it expects a "significantly higher" level of positive adjusted pre-tax income than previously.

At 1230 BST, the shares were up 5% at 152.40p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Indivior Market Data

Currency UK Pounds
Share Price 214.20p
Change Today 4.40p
% Change 2.10 %
52 Week High 215.40
52 Week Low 94.55
Volume 1,434,889
Shares Issued 725.31m
Market Cap £1,553.62m
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.9% below the market average38.9% below the market average38.9% below the market average38.9% below the market average38.9% below the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Price Trend
95.48% above the market average95.48% above the market average95.48% above the market average95.48% above the market average95.48% above the market average
96.77% above the sector average96.77% above the sector average96.77% above the sector average96.77% above the sector average96.77% above the sector average
Income Not Available
Growth
68.83% below the market average68.83% below the market average68.83% below the market average68.83% below the market average68.83% below the market average
83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for 21-Sep-2021

Time Volume / Share Price
16:35 453,128 @ 214.20p
16:29 619 @ 215.00p
16:29 6 @ 215.00p
16:29 722 @ 215.20p
16:29 158 @ 215.20p

Indivior Key Personnel

CEO Mark Crossley
Chair Graham Hetherington

Top of Page